Literature DB >> 18794395

Two-year survival and mental and psychomotor outcomes after the Norwood procedure: an analysis of the modified Blalock-Taussig shunt and right ventricle-to-pulmonary artery shunt surgical eras.

Joseph Atallah1, Irina A Dinu, Ari R Joffe, Charlene M T Robertson, Reg S Sauve, John D Dyck, David B Ross, Ivan M Rebeyka.   

Abstract

BACKGROUND: The Norwood procedure for stage 1 palliation of hypoplastic left heart syndrome is performed with either the modified Blalock-Taussig (MBTS) or the right ventricle-to-pulmonary artery (RVPA) shunt. In our institution, surgical practice changed from use of the MBTS to use of the RVPA shunt in 2002. We analyzed survival and mental and psychomotor outcomes of the 2 consecutive surgical eras. METHODS AND
RESULTS: Between September 1996 and July 2005, 94 neonates with hypoplastic left heart syndrome underwent the Norwood procedure. Patients were recruited as neonates and followed up prospectively. Health, mental, and psychomotor outcomes (Bayley Scales of Infant Development-II) were assessed at 2 years. The study subjects were from the Norwood-MBTS era (n=62; 1996 to 2002) or the Norwood-RVPA era (n=32; 2002 to 2005). In the MBTS era, early and 2-year mortality rates were 23% (14/62) and 52% (32/62); the mean (SD) mental and psychomotor developmental indices were 79 (18) and 67 (19). In the RVPA era, early and 2-year mortality rates were 6% (2/32) and 19% (6/32); the mean (SD) mental and psychomotor developmental indices were 85 (18) and 78 (18). The 2-year mortality rate (P=0.002) and the psychomotor developmental index (P=0.029) were improved in the more recent surgical era. On multivariable Cox regression analysis, postoperative highest serum lactate independently predicted 2-year mortality in the MBTS and RVPA eras.
CONCLUSIONS: Analysis of 2 consecutive surgical eras of hypoplastic left heart syndrome patients undergoing the Norwood procedure showed a significant improvement in 2-year survival and psychomotor development in the more recent era. Adverse neurodevelopmental outcome in this patient population remains a concern.

Entities:  

Mesh:

Year:  2008        PMID: 18794395     DOI: 10.1161/CIRCULATIONAHA.107.741579

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Effects of health disparities on survival after neonatal heart surgery: why should racial, ethnic, gender, and socioeconomic status be included in the risk analysis?

Authors:  Joseph J Sistino; Charles Ellis
Journal:  J Extra Corpor Technol       Date:  2011-12

2.  Factors associated with neurodevelopment for children with single ventricle lesions.

Authors:  Caren S Goldberg; Minmin Lu; Lynn A Sleeper; William T Mahle; J William Gaynor; Ismee A Williams; Kathleen A Mussatto; Richard G Ohye; Eric M Graham; Deborah U Frank; Jeffrey P Jacobs; Catherine Krawczeski; Linda Lambert; Alan Lewis; Victoria L Pemberton; Renee Sananes; Erica Sood; Stephanie B Wechsler; David C Bellinger; Jane W Newburger
Journal:  J Pediatr       Date:  2014-06-19       Impact factor: 4.406

Review 3.  Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta-analytic review.

Authors:  Joseph J Sistino; Heather Shaw Bonilha
Journal:  J Extra Corpor Technol       Date:  2012-12

Review 4.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease-What Can We Impact?

Authors:  Gil Wernovsky; Daniel J Licht
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

5.  Spatial and temporal overview of research in pediatric and congenital cardiology: trends and global challenges.

Authors:  Martina Bräutigam; Aleksander Kempny; Robert Radke; Helmut Baumgartner; Gerhard-Paul Diller
Journal:  Pediatr Cardiol       Date:  2014-03-02       Impact factor: 1.655

6.  Early results of neurodevelopment following hybrid stage I for hypoplastic left heart syndrome.

Authors:  Sharon L Cheatham; Helen Carey; Joanne L Chisolm; Jill C Heathcock; Deborah Steward
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

7.  Stem Cell Therapy for Hypoplastic Left Heart Syndrome: Mechanism, Clinical Application, and Future Directions.

Authors:  Gregory J Bittle; David Morales; Kristopher B Deatrick; Nathaniel Parchment; Progyaparamita Saha; Rachana Mishra; Sudhish Sharma; Nicholas Pietris; Alexander Vasilenko; Casey Bor; Chetan Ambastha; Muthukumar Gunasekaran; Deqiang Li; Sunjay Kaushal
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

8.  Neurodevelopmental outcomes after cardiac surgery in infancy.

Authors:  J William Gaynor; Christian Stopp; David Wypij; Dean B Andropoulos; Joseph Atallah; Andrew M Atz; John Beca; Mary T Donofrio; Kim Duncan; Nancy S Ghanayem; Caren S Goldberg; Hedwig Hövels-Gürich; Fukiko Ichida; Jeffrey P Jacobs; Robert Justo; Beatrice Latal; Jennifer S Li; William T Mahle; Patrick S McQuillen; Shaji C Menon; Victoria L Pemberton; Nancy A Pike; Christian Pizarro; Lara S Shekerdemian; Anne Synnes; Ismee Williams; David C Bellinger; Jane W Newburger
Journal:  Pediatrics       Date:  2015-05       Impact factor: 7.124

9.  Neurodevelopmental outcomes for children with hypoplastic left heart syndrome at the age of 5 years.

Authors:  Cheryl Brosig; Kathleen Mussatto; George Hoffman; Raymond G Hoffmann; Mahua Dasgupta; James Tweddell; Nancy Ghanayem
Journal:  Pediatr Cardiol       Date:  2013-03-16       Impact factor: 1.655

10.  Neurocognitive outcomes at kindergarten entry after surgical repair of total anomalous pulmonary venous connection in early infancy.

Authors:  Jonathan P Duff; Ari R Joffe; Shabnam Vatanpour; Diane M Moddemann; Charlene M T Robertson; Gwen Alton; Irina Dinu; David Ross; Ivan M Rebeyka
Journal:  Pediatr Cardiol       Date:  2014-09-11       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.